Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation-Reference-Cited by-同舟云学术

Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation

Published:2020-10-20 Issue:6 Volume:72 Page:1987-1999
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Itoh Shinji¹^ORCID,Yoshizumi Tomoharu¹,Yugawa Kyohei¹²^ORCID,Imai Daisuke¹,Yoshiya Shohei¹,Takeishi Kazuki¹,Toshima Takeo¹,Harada Noboru¹,Ikegami Toru¹,Soejima Yuji¹,Kohashi Kenichi²,Oda Yoshinao²,Mori Masaki¹

Affiliation:

1. Department of Surgery and Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan

2. Department of Anatomic Pathology Graduate School of Medical Sciences Kyushu University Fukuoka Japan

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31206

Reference29 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. Long-Term Results of Hepatic Resection Combined with Intraoperative Local Ablation Therapy for Patients with Multinodular Hepatocellular Carcinomas

3. Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis

4. Angiogenesis in liver disease

5. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study;Surgery Today;2024-08-27

2. The Association of Transferrin Receptor with Prognosis and Biologic Role in Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-08-23

3. The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis;Liver Cancer;2024-08-12

4. Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy;Surgery Today;2024-08-04

5. Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy;Journal of Hepatocellular Carcinoma;2024-07